Skip to main content

CHADS2...



CHADS2 is a widely used model for estimating stroke risk in AF.

 It estimates stroke risk in non-rheumatic AF by assigning

1 point each for Congestive heart failure, Hypertension, Age ≥ 75 years, or Diabetes mellitus

and 2 points for history of Stroke or TIA.

For example, an 82-year-old (+1) patient with hypertension (+1) and past stroke (+2) would have a CHADS2 score of 4.

Patients are considered to be at low risk with a score of 0
intermediate risk with a score of 1 or 2
and at high risk with a score 3 or more.

 Of note, a past history of cerebral ischemia without other risk factors gives only 2 points (intermediate risk), yet most experts consider these patients to be at high risk.
The majority of these patients, however, have some other risk factor and a score of at least 3.

Comments

Popular posts from this blog

The 100 essentials in icu and anesthesia

The most visual experience in anesthesia and critical care education  The 100 essentials of anesthesia and critical care  COMING VERY SOON  stay tuned 

Driving Pressure in ARDS: A new concept!

Driving Pressure and Survival in the Acute Respiratory Distress Syndrome Marcelo B.P. Amato, M.D., Maureen O. Meade, M.D., Arthur S. Slutsky, M.D., Laurent Brochard, M.D., Eduardo L.V. Costa, M.D., David A. Schoenfeld, Ph.D., Thomas E. Stewart, M.D., Matthias Briel, M.D., Daniel Talmor, M.D., M.P.H., Alain Mercat, M.D., Jean-Christophe M. Richard, M.D., Carlos R.R. Carvalho, M.D., and Roy G. Brower, M.D. N Engl J Med 2015; 372:747-755 February 19, 2015 DOI: 10.1056/NEJMsa1410639 BACKGROUND Mechanical-ventilation strategies that use lower end-inspiratory (plateau) airway pressures, lower tidal volumes (V T ), and higher positive end-expiratory pressures (PEEPs) can improve survival in patients with the acute respiratory distress syndrome (ARDS), but the relative importance of each of these components is uncertain. Because respiratory-system compliance (C RS ) is strongly related to the volume of aerated remaining functional lung during disease (termed functional lung size)...